As a traditional public health intervention, vaccines have been costing more money in recent years when a couple of newer generation of products are exhausting governments’ budgets.
The government’s re-launched universal immunisation programme had a target of achieving full immunisation by 2020. It has now decided to advance it to 2018.
The injectable vaccine was developed by British drugmaker GlaxoSmithKline to protect children from the most deadly form of malaria in Africa.
When it comes to complete immunisation–against DPT, polio and measles–only 65% of Indian children are vaccinated.